Good point stuffy. In fact when I think about it the absence of director buys of this stock at bargain prices have been deafening.
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
